ADP-ribose triggers neuronal ferroptosis by rewiring purine and pyrimidine metabolism
Rédigé par Haoqi Ni , Yingying He , Peng Cui , Hebing Chen , Guoqing Lv , Huiyan Lei , Feng Wang , Qichuan ZhuGe , Baodong Chen , Ling Liang , Yong Zhang , Fuping You et Lin Yuan
Publié 14 mai 2021
Serveur de preprints bioRxiv
Résumé
Hyperactivation of NAD + -consuming pathways frequently occurs in neurological diseases, however therapies replenishing NAD + levels show limited therapeutic efficacy, indicating more complex underlying pathophysiology. Here, we delineate a pathogenic link between ADP-ribose —a product of NAD + consumption—and a metabolic rewiring-dependent form of neuronal ferroptosis. We demonstrate that oxidative stress induces neurons to produce ADP-ribose through the PARP1-PARG axis. ADP-ribose directly binds and inhibits the equilibrative nucleoside transporter ENT2, remodeling de novo purine and pyrimidine synthesis by hyperactivating the inosine-hypoxanthine-xanthine oxidase and glutamine-dihydroorotate-dihydroorotate dehydrogenase axes. This overproduces superoxide radicals and drives lipid peroxidation and neuronal ferroptosis. Elevated ADP-ribose levels were observed in neurological disease models, and acute ADP-ribose exposure severely reduced mouse brain neurons in vivo . Critically, interventions blocking ADP-ribose signaling alleviated cognitive decline in mouse intracerebral hemorrhage models. Our findings characterize ADP-ribose signaling as linking NAD + consumption to neuronal ferroptosis, and provide a theraputic strategy for neuropathologies involving NAD + consumption and oxidative stress.
Lire le preprint